NCT05842512: Study of ADI-PEG 20 Versus Placebo in Subjects With NASH
- State
- Under way
- Phase
- Phase 2
- People
- 60 planned
- Started
- 13 Sep 2023
- Primary completion
- 31 Dec 2027
- Arms
- Drug: ADI-PEG 20
- Results
- None posted
- 6 May 2023: Trial registered
- 13 Sep 2023: Trial started